Key Opinion Leaders’ Influences in the Chinese Fashion Market

2019 ◽  
pp. 118-132 ◽  
Author(s):  
Yushan Zou ◽  
Fanke Peng
Keyword(s):  
Opinion Leaders ◽  
Key Opinion Leaders

Identifying Key Opinion Leaders in Social Media via Modality-Consistent Harmonized Discriminant Embedding

2020 ◽  
Vol 50 (2) ◽  
pp. 717-728 ◽  
Author(s):  
Yang Liu ◽  
Zhonglei Gu ◽  
Tobey H. Ko ◽  
Jiming Liu
Keyword(s):  
Social Media ◽  
Opinion Leaders ◽  
Key Opinion Leaders

scholarly journals Key opinion leaders’ guide to spinning a disappointing clinical trial result

BMJ ◽  
2018 ◽  
pp. k5207
Author(s):  
Adam Hartley ◽  
Mit Shah ◽  
Alexandra N Nowbar ◽  
Christopher Rajkumar ◽  
James P Howard ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Trial Result ◽  
Opinion Leaders ◽  
Clinical Trial Result ◽  
Key Opinion Leaders

scholarly journals Should the drug industry work with key opinion leaders? No

BMJ ◽  
2008 ◽  
Vol 336 (7658) ◽  
pp. 1405-1405 ◽  
Author(s):  
Giovanni A Fava
Keyword(s):  
Opinion Leaders ◽  
Drug Industry ◽  
Key Opinion Leaders

Editor's Memo

2021 ◽  
Vol 19 (2) ◽  
Author(s):  
Robert Figlin
Keyword(s):  
Cancer Research ◽  
Health Equity ◽  
Cancer Care ◽  
Scientific Collaboration ◽  
Opinion Leaders ◽  
High Quality ◽  
Quality Cancer Care ◽  
Key Opinion Leaders ◽  
American Society ◽  
Silver Lining

The COVID-19 pandemic has exposed fundamental disparities in the provision of health care across our nation and exacerbated the differences in health outcomes associated with race, socioeconomic and other demographic factors. A silver lining however is that pandemic precarity has inspired tremendous scientific collaboration among clinicians, researchers, and key opinion leaders. In this line, this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO21) which was kicked off virtually on June 4 through June 8, not only celebrated latest breakthroughs in cancer research, treatment and patient care, but also focused on health equity in cancer care. ASCO21’s fitting theme - Health equity “doing right by the patients for whom we care” reflected addressing complex forces and systems that have created disparities in cancer care, treatment, and research and identifying ways to ensure that all patients have access to and benefit from the latest cancer advances and high-quality cancer care.

KOLs

2021 ◽  
pp. 139-162
Author(s):  
Edward Shorter
Keyword(s):  
Pharmaceutical Industry ◽  
Marketing Strategies ◽  
Opinion Leaders ◽  
True Nature ◽  
Key Opinion Leaders ◽  
Effective Compound

This chapter considers the physicians who advised the pharmaceutical industry in the interest of bringing an effective compound to the attention of the profession. It mentions Roland Kuhn, the Swiss asylum psychiatrist who in 1957 discovered the effectiveness of imipramine in depression and advised about marketing strategies to use to sell the drug. It also highlights the true nature of the testimonials of physicians, which is well known to the industry. The industry’s contempt for them is shown by its vernacular term for sources, which are called “stables.” The chapter focuses on the “stables” of the 1980s that later became Key Opinion Leaders (KOLs). It points out that the sardonic term KOL first appeared in industry correspondence as an insider expression for academics.

A systematic review of the compression regimes used in randomised clinical trials following endovenous ablation

2016 ◽  
Vol 32 (4) ◽  
pp. 256-271 ◽  
Author(s):  
Joseph El-Sheikha ◽  
Daniel Carradice ◽  
Sandip Nandhra ◽  
Clement Leung ◽  
George E Smith ◽  
...  
Keyword(s):  
Systematic Review ◽  
Clinical Trials ◽  
Varicose Veins ◽  
Opinion Leaders ◽  
Randomised Clinical Trials ◽  
Marked Variation ◽  
Insufficient Evidence ◽  
Endovenous Ablation ◽  
Key Opinion Leaders ◽  
Over Time

Objectives There is insufficient evidence to inform guidelines on the optimal compression strategy following ablation for varicose veins. This study aimed to identify the practice of key opinion leaders performing randomised clinical trials involving endovenous ablation. Method A systematic review of MEDLINE/EMBASE/CENTRAL was performed identifying the compression strategies used in randomised clinical trials where at least one comparator arm underwent endovenous ablation. Results Thirty-four randomised clinical trials were identified. At least 14 different compression products were used, with at least 6 different pressures in 7 different regimes with durations from 2 to 84 days. There was no evidence of any convergence of practice over time. Conclusions A lack of evidence as to the optimal strategy for compression has resulted in a marked variation in clinical practice. There is no suggestion that this variation is becoming less over time indicating that experience is not helping to form a consensus and, therefore, further research is required.

Preventing surgical site infection: conclusions from experts at EWMA

2019 ◽  
Vol 28 (7) ◽  
pp. 466-468
Keyword(s):  
Surgical Site Infection ◽  
Surgical Site Infections ◽  
Opinion Leaders ◽  
Site Infection ◽  
Infection Rates ◽  
Key Opinion Leaders

In an Essity-sponsored symposium, titled ‘Surgical site infection rates still high? We need to do more,’ key opinion leaders discussed the importance of identifying, preventing and treating surgical site infections (SSI). Fatima Bibi summarises the main points presented at EWMA 2019.

Sign in / Sign up

Export Citation Format

Share Document